首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5005篇
  免费   565篇
  国内免费   8篇
耳鼻咽喉   16篇
儿科学   135篇
妇产科学   82篇
基础医学   327篇
口腔科学   178篇
临床医学   485篇
内科学   614篇
皮肤病学   43篇
神经病学   233篇
特种医学   194篇
外科学   467篇
综合类   74篇
一般理论   3篇
预防医学   2094篇
眼科学   96篇
药学   182篇
中国医学   7篇
肿瘤学   348篇
  2023年   43篇
  2022年   70篇
  2021年   61篇
  2020年   102篇
  2019年   44篇
  2018年   119篇
  2017年   116篇
  2016年   117篇
  2015年   131篇
  2014年   142篇
  2013年   249篇
  2012年   132篇
  2011年   155篇
  2010年   171篇
  2009年   202篇
  2008年   157篇
  2007年   162篇
  2006年   172篇
  2005年   153篇
  2004年   160篇
  2003年   137篇
  2002年   183篇
  2001年   170篇
  2000年   139篇
  1999年   223篇
  1998年   185篇
  1997年   210篇
  1996年   229篇
  1995年   153篇
  1994年   69篇
  1993年   143篇
  1992年   72篇
  1991年   57篇
  1990年   68篇
  1989年   64篇
  1988年   82篇
  1987年   47篇
  1986年   80篇
  1985年   52篇
  1984年   46篇
  1983年   48篇
  1982年   38篇
  1981年   33篇
  1980年   32篇
  1979年   30篇
  1978年   38篇
  1977年   23篇
  1976年   36篇
  1975年   25篇
  1970年   21篇
排序方式: 共有5578条查询结果,搜索用时 15 毫秒
1.
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of comorbidities increases and care involves multiple healthcare providers from multiple subspecialties. This occurs in the context of a fragmented US healthcare delivery system that is traditionally siloed by provider specialty, organization, as well as systems of payment and administration. This article describes the role of care fragmentation in the delivery of optimal ESKD care and identifies research gaps in the evidence across the continuum of care. We then consider the impact of care fragmentation on ESKD care from the patient and health system perspectives and explore opportunities for system-level interventions aimed at improving care for patients with ESKD.  相似文献   
2.
3.
4.
5.
Objectives Compare the effect of high doses of inhaled corticosteroids on bone loss in subjects with moderate to severe asthma or mild asthma, and examine the influence of dietary intake on bone metabolism. Design A survey on the effects of corticotherapy and nutrition on bone density was conducted in 74 subjects currently being treated for asthma in the asthma clinic of Hospital Laval (Sainte-Foy, Quebec, Canada). Fifty-eight subjects completed the study (attrition RATE=15%).

Main outcome measures In all subjects expiratory volumes were determined and urinary analysis was conducted for hydroxyproline, calcium, phosphorus, and cortisol levels. Osteocalcin, calcium, phosphorus, cortisol, alkaline phosphatase, and γ-glutamyltransferase levels were measured in blood samples. Bone density of the lumbar spine was determined by means of dual-energy x-ray absorptiometry. Nutrition evaluation was based on a 3-day food diary analyzed using progiciel Nutri 91. The nutritional parameters examined were calcium; phosphorus; magnesium; zinc; vitamins A, C, and D; protein; total fiber; oxalates; energy; caffeine; and alcohol in relation to bone density.

Subjects Thirty-one patients with moderate to severe asthma who had been taking more than 1,000 μg beclomethasone per day or the equivalent for more than 2 years and 27 patients with mild asthma who were taking less than 500 μg beclomethasone per day or the equivalent.

Statistical analyses performed Four factor analysis of variance with hierarchized interactions of four levels, Duncan's test, Pearson correlation coefficients.

Results Blood levels of osteocalcin and protein intake were lower in patients with moderate to severe asthma than in those with mild asthma (P<.05). Significant correlations (P<.02) were observed between bone density and calcium intake (r=.40), phosphorus intake (r=.35), protein intake (r=.30), and serum alkaline phosphatase level (r=−.30). Bone density was not significantly different between the two groups of patients with asthma.

Applications A follow-up of patients with asthma who are taking inhaled corticosteroids is needed to assess bone density, osteocalcin levels, and dietary intakes of calcium. Verify if osteocalcin level decreases over time in patients with moderate to severe asthma, monitor possible modifications in bone density, and verify if the correlation between dietary calcium and bone density is maintained. J Am Diet Assoc. 1997;97:1401–1406.  相似文献   

6.
7.
Sonoelasticity imaging of prostate cancer: in vitro results   总被引:2,自引:0,他引:2  
  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号